학술논문

A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults
Document Type
Article
Source
In Vaccine 30 April 2024 42(12):3066-3074
Subject
Language
ISSN
0264-410X